+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Discovery Market Research Reports

Extractables and Leachables Testing for Polymeric Materials Used in Pharmaceutical Industry: An Introduction and Strategies in Current Practice - Product Thumbnail Image

Extractables and Leachables Testing for Polymeric Materials Used in Pharmaceutical Industry: An Introduction and Strategies in Current Practice

  • Training
  • 60 Minutes
  • Global
GMP Data Integrity Best Practices and Regulatory Expectations for the Pharmaceutical Industry - Product Thumbnail Image

GMP Data Integrity Best Practices and Regulatory Expectations for the Pharmaceutical Industry

  • Training
  • 90 Minutes
  • Global
FDA's new enforcement initiative - Strategic Software Validation Planning for Executives and Managers - Product Thumbnail Image

FDA's new enforcement initiative - Strategic Software Validation Planning for Executives and Managers

  • Training
  • 60 Minutes
  • Global
Drug Product Performance, In Vivo: Bioavailability and Bioequivalence - Product Thumbnail Image

Drug Product Performance, In Vivo: Bioavailability and Bioequivalence

  • Training
  • 90 Minutes
  • Global
Cosmetic Testing for US FDA Compliance - Product Thumbnail Image

Cosmetic Testing for US FDA Compliance

  • Training
  • 75 Minutes
  • United States
Quality Assurance at the (Clinical Research) Site: How to Develop a Manageable Plan - Product Thumbnail Image

Quality Assurance at the (Clinical Research) Site: How to Develop a Manageable Plan

  • Training
  • 60 Minutes
  • Global
Fraud in Clinical Research - Product Thumbnail Image

Fraud in Clinical Research

  • Training
  • 60 Minutes
  • Global
Pediatric Drug Development - Relevant FDA Laws and Changing Approach - Product Thumbnail Image

Pediatric Drug Development - Relevant FDA Laws and Changing Approach

  • Training
  • 60 Minutes
  • Global
Driving Quality and Compliance in Drug Development Through the FDA End-of-Phase 2A Meeting - Product Thumbnail Image

Driving Quality and Compliance in Drug Development Through the FDA End-of-Phase 2A Meeting

  • Training
  • 60 Minutes
  • Global
Health Canada's Enforcement of the Regulatory Requirements for the Manufacture, Advertising and Sale of Pharmaceuticals, Medical Devices and Natural Health Products - Product Thumbnail Image

Health Canada's Enforcement of the Regulatory Requirements for the Manufacture, Advertising and Sale of Pharmaceuticals, Medical Devices and Natural Health Products

  • Training
  • 60 Minutes
  • Canada
Lean Approaches to Development of HPLC Methods for Drug Products - Product Thumbnail Image

Lean Approaches to Development of HPLC Methods for Drug Products

  • Training
  • 90 Minutes
  • Global
Introduction of Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA / CDER - Product Thumbnail Image

Introduction of Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA / CDER

  • Training
  • 90 Minutes
  • Global
Marketing Beverages, Fruit Juice and Sports Drinks in Compliance with FDA Regulations - Product Thumbnail Image

Marketing Beverages, Fruit Juice and Sports Drinks in Compliance with FDA Regulations

  • Training
  • 60 Minutes
  • Global
Auditing Analytical Laboratories for FDA Compliance - Product Thumbnail Image

Auditing Analytical Laboratories for FDA Compliance

  • Training
  • 60 Minutes
  • Global
Practical Process Validation Part 1 - Validation Planning, Prerequisites and Best Practices - Product Thumbnail Image

Practical Process Validation Part 1 - Validation Planning, Prerequisites and Best Practices

  • Training
  • 90 Minutes
  • Global
Basic USDA and FDA Food Labeling: Learn to Create Labels in Compliance with Regulations and Understand the Essential Elements of Labels - Product Thumbnail Image

Basic USDA and FDA Food Labeling: Learn to Create Labels in Compliance with Regulations and Understand the Essential Elements of Labels

  • Training
  • 60 Minutes
  • Global
Quality Expectations for Drugs and Biologics during Early Development: Phase 3 and NDA - Product Thumbnail Image

Quality Expectations for Drugs and Biologics during Early Development: Phase 3 and NDA

  • Training
  • 75 Minutes
  • Global
Deploying Regulatory-Compliant Clinical Research Data Management Systems - Product Thumbnail Image

Deploying Regulatory-Compliant Clinical Research Data Management Systems

  • Training
  • 60 Minutes
  • Global
How to Prepare for FDA Compliance - Product Thumbnail Image

How to Prepare for FDA Compliance

  • Training
  • 60 Minutes
  • Global
Auditing Analytical Laboratories for FDA Compliance - Product Thumbnail Image

Auditing Analytical Laboratories for FDA Compliance

  • Training
  • 60 Minutes
  • Global
Loading Indicator

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs. The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more